← Open Payments lookup

EMMANUEL APPIADU: Open Payments

NPI 1770913444 · YULEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,086 in 77 payments from 15 companies in 2025. Trend: 2023 $1,600 · 2024 $2,562 · 2025 $2,086

Food & beverage: $1,974Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$345
Janssen Pharmaceuticals, Inc6$309
Neurocrine BioSciences, Inc.8$285
Teva Pharmaceuticals USA, Inc.10$233
Supernus Pharmaceuticals, Inc.9$176
Vanda Pharmaceuticals Inc.6$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$142
E.R. Squibb & Sons, L.L.C.5$121
Takeda Pharmaceuticals U.S.A., Inc.4$95
Alkermes, Inc.3$77

Products named: INGREZZA, Qelbree, SPRAVATO, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, CAPLYTA, COBENFY.

Industry payments across FL — which companies pay providers there.